1. Early and Late Histological and Ultrastructural Findings in Resected Infantile Capillary Hemangiomas Following Treatment with Topical Beta-Blocker Timolol Maleate 0.5%
   Zuzana Sipkova et al, 2018, Ocular Oncology and Pathology CrossRef
2. Infantile Hemangiomas, Retinopathy of Prematurity and Cancer: A Common Pathogenetic Role of the β‐Adrenergic System
   Luca Filippi et al, 2015, Medicinal Research Reviews CrossRef
3. Time-dependent homeostasis between glucose uptake and consumption in astrocytes exposed to CoCl2 treatment
   PENG WANG et al, 2016, Molecular Medicine Reports CrossRef
4. The Rho/Rac Guanine Nucleotide Exchange Factor Vav1 Regulates Hif-1α and Glut-1 Expression and Glucose Uptake in the Brain
   Jaewoo Hong et al, 2020, International Journal of Molecular Sciences CrossRef
5. Role of hypoxia preconditioning in therapeutic potential of mesenchymal stem-cell-derived extracellular vesicles
   Victoria Pulido-Escribano et al, 2022, World Journal of Stem Cells CrossRef
6. The role of dendritic cells and their immunometabolism in rheumatoid arthritis
   Yuichi Suwa et al, 2023, Frontiers in Immunology CrossRef
7. GSH-related enzyme activity and tumor relation: glutathione peroxidase and glutathione reductase status under hypoxia in HepG2 cells
   Ozen Ozensoy Guler et al, 2024, Turkish Journal of Biochemistry CrossRef
8. Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial
   Luca Filippi et al, 2017, BMC Pediatrics CrossRef
9. Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression
   Francesca Pascarella et al, 2024, Frontiers in Pediatrics CrossRef
10. Metabolomics in rheumatoid arthritis: Advances and review
    Lingxia Xu et al, 2022, Frontiers in Immunology CrossRef